新药临床试验期间药物警戒和风险控制研究六:完善新药临床试验期间药物警戒和风险控制监管体系的建议
左晓春, 冯红云, 智会静, 周凌芸, 李浩, 吕心欢, 邵颖, 杨建红, 张象麟
中国药事 ›› 2022, Vol. 36 ›› Issue (6) : 659-663.
新药临床试验期间药物警戒和风险控制研究六:完善新药临床试验期间药物警戒和风险控制监管体系的建议
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Research VI on Pharmacovigilance and Risk Control During Clinical Trials of New Drugs: Suggestions for Improving the Supervision System of Pharmacovigilance and Risk Control During Clinical Trail of New Drugs
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
